Country: Malta
Language: English
Source: Medicines Authority
SODIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, HEXAHYDRATE, SODIUM ACETATE, TRIHYDRATE, SODIUM GLUCONATE
Baxter Holding B.V. Kobaltweg 49, 3542CE Utrecht, Netherlands
B05BB01
SODIUM CHLORIDE 5.26 g/l POTASSIUM CHLORIDE 0.37 g/l MAGNESIUM CHLORIDE HEXAHYDRATE 0.30 g/l SODIUM ACETATE TRIHYDRATE 3.68 g/l SODIUM GLUCONATE 5.02 g/l
SOLUTION FOR INFUSION
SODIUM CHLORIDE 5.26 g/l POTASSIUM CHLORIDE 0.37 g/l MAGNESIUM CHLORIDE HEXAHYDRATE 0.30 g/l SODIUM ACETATE TRIHYDRATE 3.68 g/l SODIUM GLUCONATE 5.02 g/l
POM
BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
Authorised
2016-11-11
1 PACKAGE LEAFLET: INFORMATION FOR THE USER PLASMA-LYTE ® 148 (PH 7.4) SOLUTION FOR INFUSION Active substances: sodium chloride, potassium chloride, magnesium chloride hexahydrate, sodium acetate trihydrate and sodium gluconate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or nurse. - If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. See section 4. This medicine is called `Plasma-Lyte ® 148 (pH 7.4) Solution for Infusion’, but will be referred to as `Plasma- Lyte ® 148 (pH 7.4) infusion’ throughout the remainder of this leaflet. WHAT IS IN THIS LEAFLET : 1. What Plasma-Lyte ® 148 (pH 7.4) Infusion is and what it is used for 2. What you need to know before you use Plasma-Lyte ® 148 (pH 7.4) Infusion 3. How to use Plasma-Lyte ® 148 (pH 7.4) Infusion 4. Possible side effects 5. How to store Plasma-Lyte ® 148 (pH 7.4) Infusion 6. Contents of the pack and other information WHAT PLASMA-LYTE® 148 (PH 7.4) INFUSION IS AND WHAT IT IS USED FOR Pharmacotherapeutic group: “Electrolytes” - ATC code: “B05BB01” Plasma-Lyte ® 148 (pH 7.4) Infusion is a solution of the following substances in water: - sodium chloride - potassium chloride - magnesium chloride hexahydrate - sodium acetate trihydrate - sodium gluconate Sodium, potassium, magnesium, chloride, acetate and gluconate are chemical substances found in the blood. Plasma-Lyte ® 148 (pH 7.4) infusion is used: - to provide a source of fluid, for example in cases of: - burns - head injury - fractures - infection - peritoneal irritation (inflammations within the abdomen) - as a source of fluids during a surgical operation - for the treatment of shock due to loss of blood and for other conditions needing rapid replacement of blood and/or fluids - in metabolic acidosis (when the blood becomes too acid) t Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Plasma-Lyte ® 148 (pH 7.4) solution for infusion. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Sodium Chloride:......................................................................................................... 5.26 g/l Potassium Chloride:..................................................................................................... 0.37 g/l Magnesium Chloride hexahydrate: .............................................................................. 0.30 g/l Sodium Acetate trihydrate: .......................................................................................... 3.68 g/l Sodium Gluconate: ...................................................................................................... 5.02 g/l Na + K + Mg ++ Cl - CH 3 COO - C 6 H 11 O 7 - (Acetate) (Gluconate) mmol/l 140 5.0 1.5 98 27 23 mEq/l 140 5.0 3.0 98 27 23 For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for infusion. Clear solution, free from visible particles Osmolarity: 295 mOsm/l (approx.) pH: approx. 7.4 (6.5 to 8.0) 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Plasma-Lyte 148 (pH 7.4) is indicated: - for fluid replacement (e.g. after burns, head injury, fracture, infection, and peritoneal irritation), - as intraoperative fluid replacement, - in haemorrhagic shock and clinical conditions requiring rapid blood transfusions (compatibility with blood), - in mild to moderate metabolic acidosis, also in case of lactate metabolism impairment. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology: _ADULTS, OLDER PATIENTS AND ADOLESCENTS (AGE 12 YEARS AND OVER): _ Fluid balance, serum electrolytes and acid-base balance should be monitored before and during administration, with particular attention to serum sodium in patients with increased non-osmotic vasopressin release (syndrome of inappropriate antidiuretic hormone secretion, SIADH) and in patients co-medicated with vasopressin agonist drugs, due to the risk of hospital acquir Read the complete document